Research Articles
A Shield for Two: How HIV Treatment Protects Mothers and Their Babies
Explore how Antiretroviral Therapy (ART) creates a protective shield for both mothers with HIV and their unborn babies, preventing mother-to-child transmission.
A Single-Tablet Revolution: Simplifying HIV Treatment for Kidney Failure Patients
Breakthrough research shows B/F/TAF single-tablet regimen offers safe, effective HIV treatment for patients with end-stage renal disease on hemodialysis.
The Silent Sentinel: How HIV's Capsid Became Medicine's Most Promising Target
Explore the research trends in HIV-1 capsid inhibitors from 2000-2022, including structural insights, clinical developments, and future therapeutic directions.
HIV and AIDS: 20 Years of Scientific Revolution
Explore the groundbreaking scientific discoveries in HIV and AIDS research over the past two decades, from capsid revelations to innovative cure strategies.
The Gray Zone: What Low-Level Viremia Means for Women Living with HIV
Understanding low-level viremia and its implications for women living with HIV, including treatment outcomes and long-term health considerations.
The Changing Face of HIV in Senegal: From Risky Groups to Risky Places
Exploring Senegal's innovative HIV research approaches, from concentrated epidemics to the PLACE methodology mapping transmission hotspots.
The Hidden Enemy: How Modern Science is Closing in on an HIV Cure
Explore the latest breakthroughs in HIV cure research, from shock-and-kill strategies to mRNA technology and gene editing approaches.
Unlocking HIV's Secrets: How a Simple Blood Spot is Revolutionizing Viral Monitoring
Discover how dried blood spots are transforming HIV monitoring in resource-limited settings through innovative RNA extraction methods.
A Five-Year Victory: Powerful HIV Treatment Proves Its Mettle in Tough Cases
New five-year data confirms Bictegravir/Emtricitabine/Tenofovir Alafenamide effectively treats advanced HIV cases with high viral loads and low CD4 counts.
A Simpler Path: How Treatment Switching Is Transforming HIV Management
Exploring how switching to RPV/TDF/FTC single-tablet regimen maintains viral suppression while improving lipid profiles in HIV patients.